News stories about UnitedHealth Group (NYSE:UNH) have been trending somewhat positive this week, according to Accern. The research firm scores the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. UnitedHealth Group earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave news articles about the healthcare conglomerate an impact score of 47.9240718680277 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

UNH has been the topic of a number of recent research reports. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Sanford C. Bernstein restated an “outperform” rating and set a $210.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, October 10th. Jefferies Group upped their price objective on UnitedHealth Group from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Friday, October 13th. Finally, BMO Capital Markets initiated coverage on UnitedHealth Group in a research report on Monday, October 16th. They set an “outperform” rating and a $250.00 price objective on the stock. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $243.22.

Shares of UnitedHealth Group (NYSE UNH) traded up $0.21 during midday trading on Monday, hitting $243.56. The stock had a trading volume of 4,009,197 shares, compared to its average volume of 3,708,564. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.70 and a current ratio of 0.73. UnitedHealth Group has a 12-month low of $156.49 and a 12-month high of $244.35. The stock has a market capitalization of $235,490.00, a P/E ratio of 22.74, a price-to-earnings-growth ratio of 1.42 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The firm had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. During the same period in the prior year, the business posted $2.11 earnings per share. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. research analysts expect that UnitedHealth Group will post 12.52 EPS for the current year.

In related news, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the transaction, the chief executive officer now owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. In the last three months, insiders sold 33,853 shares of company stock worth $7,517,108. 0.89% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group (UNH) Receiving Somewhat Favorable Media Coverage, Report Finds” was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with's FREE daily email newsletter.